Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
Monoisotopic mass
284.071640755
InChI
InChI=1S/C16H13ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3
InChI Key
InChIKey=AAOVKJBEBIDNHE-UHFFFAOYSA-N
IUPAC Name
7-chloro-1-methyl-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one
Traditional IUPAC Name
diazepam
SMILES
CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1
Độ hòa tan
50 mg/L (at 25 °C)
pKa (Strongest Basic)
2.92
Refractivity
79.81 m3·mol-1
Dược Lực Học :
Diazepam, a benzodiazepine, generates the same active metabolite as chlordiazepoxide and clorazepate. In animals, diazepam appears to act on parts of the limbic system, the thalamus and hypothalamus, and induces calming effects. Diazepam, unlike chlorpromazine and reserpine, has no demonstrable peripheral autonomic blocking action, nor does it produce extrapyramidal side effects; however, animals treated with diazepam do have a transient ataxia at higher doses. Diazepam was found to have transient cardiovascular depressor effects in dogs. Long-term experiments in rats revealed no disturbances of endocrine function. Injections into animals have produced localized irritation of tissue surrounding injection sites and some thickening of veins after intravenous use.
Cơ Chế Tác Dụng :
A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of gamma-aminobutyric acid activity. It is used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome. (From Martindale, The Extra Pharmacopoeia, 30th ed, p589)
Benzodiazepines bind nonspecifically to benzodiazepine receptors which mediate sleep, affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell.
Dược Động Học :
▧ Absorption :
Essentially complete, with a bioavailability of 93%.
▧ Volume of Distribution :
* 0.8 to 1.0 L/kg [young healthy males]
▧ Protein binding :
98.5%
▧ Metabolism :
Hepatic via the Cytochrome P450 enzyme system. The main active metabolite is desmethyldiazepam, in addition to minor active metabolites including temazepam and oxazepam.
▧ Route of Elimination :
Diazepam and its metabolites are excreted mainly in the urine, predominantly as their glucuronide conjugates.
▧ Half Life :
Biphasic 1-2 days and 2-5 days, active metabolites with long half lives.
▧ Clearance :
* 20-30 mL/min
Độc Tính :
Symptoms of overdose include somnolence, confusion, coma, and diminished reflexes. Respiration, pulse and blood pressure should be monitored.
Chỉ Định :
Used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome.
Tương Tác Thuốc :
-
Amprenavir
Amprenavir may increase the effect and toxicity of the benzodiazepine, diazepam.
-
Cimetidine
Cimetidine may increase the effect of the benzodiazepine, diazepam.
-
Clarithromycin
The macrolide, clarithromycin, may increase the effect of the benzodiazepine, diazepam.
-
Clozapine
Increased risk of toxicity
-
Digoxin
The benzodiazepine, diazepam, may increase the effect of digoxin.
-
Erythromycin
The macrolide, erythromycin, may increase the effect of the benzodiazepine, diazepam.
-
Ethotoin
Ethotoin may increase the metabolism of diazepam via CYP3A4.
-
Etravirine
Diazepam (a CYP21C9 and CYP3A4 substrate), when administered concomitantly with etravirine, may experience an increase (via CYP21C9 inhibition) or a decrease(via CYP3A4 induction) in serum concentration. Overall clinical significance is unknown. It is recommended to monitor diazepam therapy.
-
Fluconazole
Fluconazole may increase the effect of the benzodiazepine, diazepam.
-
Fosamprenavir
Fosamprenavir may increase the effect and toxicity of the benzodiazepine, diazepam.
-
Fosphenytoin
Fosphenytoin may increase the metabolism of diazepam via CYP3A4.
-
Indinavir
The protease inhibitor, indinavir, may increase the effect of the benzodiazepine, diazepam.
-
Itraconazole
Itraconazole may increase the effect of the benzodiazepine, diazepam.
-
Josamycin
The macrolide, josamycin, may increase the effect of the benzodiazepine, diazepam.
-
Kava
Kava may increase the effect of the benzodiazepine, diazepam.
-
Ketoconazole
Ketoconazole may increase the effect of the benzodiazepine, diazepam.
-
Mephenytoin
Mephenytoin may increase the metabolism of diazepam via CYP3A4.
-
Nelfinavir
The protease inhibitor, nelfinavir, may increase the effect of the benzodiazepine, diazepam.
-
Omeprazole
Omeprazole may increase the effect of the benzodiazepine, diazepam.
-
Phenytoin
Phenytoin may increase the metabolism of diazepam via CYP3A4.
-
Quinupristin
This combination presents an increased risk of toxicity
-
Rifampicin
Rifampin may decrease the effect of the benzodiazepine, diazepam.
-
Ritonavir
The protease inhibitor, ritonavir, may increase the effect of the benzodiazepine, diazepam.
-
Saquinavir
The protease inhibitor, saquinavir, may increase the effect of the benzodiazepine, diazepam.
-
St. John's Wort
St. John's Wort may decrease the effect of the benzodiazepine, diazepam.
-
Telithromycin
Telithromycin may reduce clearance of Diazepam. Consider alternate therapy or monitor for changes in the therapeutic/adverse effects of Diazepam if Telithromycin is initiated, discontinued or dose changed.
-
Ticlopidine
Ticlopidine may decrease the metabolism and clearance of Diazepam. Consider alternate therapy or monitor for adverse/toxic effects of Diazepam if Ticlopidine is initiated, discontinued or dose changed.
-
Tipranavir
Tipranavir may decrease the metabolism and clearance of Diazepam. Consider alternate therapy or monitor for Diazepam toxic effects if Tipranavir is initiated or dose increased.
-
Triprolidine
The CNS depressants, Triprolidine and Diazepam, may increase adverse/toxic effects due to additivity. Monitor for increased CNS depressant effects during concomitant therapy.
-
Voriconazole
Voriconazole may increase the serum concentration of diazepam by decreasing its metabolism. Monitor for diazepam toxicity if voriconazole is initiated or dose increased.
Liều Lượng & Cách Dùng :
Emulsion - Intramuscular
Gel - Rectal
Solution - Intramuscular
Solution - Oral
Tablet - Oral
Dữ Kiện Thương Mại
Giá thị trường
-
Giá bán buôn : USD >1.23
Đơn vị tính : ml
-
Giá bán buôn : USD >2.43
Đơn vị tính : tablet
-
Giá bán buôn : USD >2.55
Đơn vị tính : tablet
-
Giá bán buôn : USD >3.99
Đơn vị tính : g
-
Giá bán buôn : USD >6.06
Đơn vị tính : tablet
-
Giá bán buôn : USD >362.12
Đơn vị tính : each
-
Giá bán buôn : USD >413.6
Đơn vị tính : box
-
Giá bán buôn : USD >423.95
Đơn vị tính : box
-
Giá bán buôn : USD >429.58
Đơn vị tính : each
-
Giá bán buôn : USD >429.58
Đơn vị tính : kit
-
Giá bán buôn : USD >0.05
Đơn vị tính : tablet
-
Giá bán buôn : USD >0.07
Đơn vị tính : tablet
-
Giá bán buôn : USD >0.09
Đơn vị tính : tablet
-
Giá bán buôn : USD >0.17
Đơn vị tính : ml
-
Giá bán buôn : USD >0.26
Đơn vị tính : tablet
-
Giá bán buôn : USD >0.3
Đơn vị tính : tablet
-
Giá bán buôn : USD >0.38
Đơn vị tính : tablet
-
Giá bán buôn : USD >0.69
Đơn vị tính : ml
Nhà Sản Xuất
-
Sản phẩm biệt dược : Diapam
-
Sản phẩm biệt dược : Diastat
-
Sản phẩm biệt dược : Diazemuls
-
Sản phẩm biệt dược : Nervium
-
Sản phẩm biệt dược : Relanium
-
Sản phẩm biệt dược : Valium
Tài Liệu Tham Khảo Thêm
National Drug Code Directory